Summary
The product METHAN, manufactured by Driada Medical, underwent analytical testing to verify its composition and potency. The sample, identified by batch number 970003, was analyzed by Janoshik Analytical, a laboratory specializing in pharmaceutical quality control. The analysis confirmed the presence of methandienone, with a measured concentration of 10.99 mg per pill. This result slightly exceeds the specification of 10 mg per pill, reflecting an accuracy of 109.9% and a variance of 9.9% above the label claim.
Testing was commissioned and funded by the manufacturer, Driada Medical. The sample was tested twice to ensure the accuracy of the findings, with the analysis completed on 28 February 2022. While the results align closely with the label claims, the manufacturer’s involvement warrants careful scrutiny of these findings. This report aims to provide an educational and harm reduction perspective, helping users evaluate product quality in a transparent manner.
Detailed Report
Product Overview
- Manufacturer: Driada Medical
- Product Name: METHAN
- Active Ingredient: Methandienone
- Batch Number: 970003
- Expiration Date: Not provided
- Delivery Method: Oral
Sample Acquisition and Testing
- Task Number: #18693
- Testing Ordered: 21 February 2022
- Sample Received: 22 February 2022
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: Driada Medical
- Analysis Paid For By: Driada Medical
Testing Results
- Specification: 10 mg per pill (as stated on the label)
- Measured Concentration: 10.99 mg per pill
- Accuracy: 109.9% (9.9% above the label claim)
Verification Details
- Verification URL: https://janoshik.com/tests/18693_I4ABN72TDQ2Z
- Originally Published: https://thinksteroids.com/community/posts/2920247/
Evaluation of Manufacturer-Funded Testing
Since the testing for METHAN was both submitted and paid for by Driada Medical, it is essential to approach the results with a degree of skepticism. Manufacturer-funded testing can introduce potential biases, such as selective sampling of optimal batches. However, Janoshik Analytical’s established reputation for reliable testing and transparency helps mitigate these concerns. The confirmation of results through repeated retesting further strengthens their validity.
To enhance consumer confidence, complementary independent testing from third-party laboratories would provide a more comprehensive evaluation of the product’s consistency and quality.
Conclusion
The analysis of METHAN by Driada Medical demonstrates an accurate concentration of methandienone, slightly exceeding the labeled specification. While the results validate the product’s potency, independent verification would add further assurance for consumers. This report underscores the importance of transparent testing in harm reduction, helping users make informed decisions about anabolic steroid products.
Disclaimer
This report is published for educational and harm reduction purposes. Manufacturer-funded testing may involve inherent biases; however, it can still provide useful data when critically assessed alongside third-party or independent results. Readers are encouraged to use this information responsibly.
